CELC · Celcuity Inc.
$92.00
+5.40 (+6.24%)
At close · Aug 14
Market Cap
$4.50B
Shares
48.93M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-07-14 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-07-14 | REVTORPYK FDA Approval Conference Call | Conference |
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference 2026 | Conference |
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-06-02 | Phase 3 VIKTORIA-1 PIK3CA Mutant Cohort Clinical Trial Results Conference Call | Earnings call |
| 2026-05-14 | First Quarter 2026 Financial Results and Webcast/Conference Call | Earnings call |
| 2026-03-25 | Fourth Quarter 2025 Financial Results and Webcast/Conference Call | Earnings call |
| 2025-10-20 | Phase 3 VIKTORIA-1 HR+/HER2-/PIK3CA WT Trial Results Presentation | Presentation |
Key facts
CIK
1603454
CUSIP
15102K100
13F (30d)
265 filings
264 filers
Visit website
Investor relations